Delivery Order SPE2DR25D1201-SPE2DR26FAKGR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription pharmaceutical product used in treating autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,154.12 and is scheduled for completion by December 31, 2025. The contract was awarded competitively with no set-aside designation, and performance will be executed from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mL, a biological pharmaceutical used to treat autoimmune conditions. The contract is valued at $9,065.07 with a firm fixed price structure and an ultimate completion date of December 15, 2025. This is a non-set-aside award, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $13,730.83, is scheduled for completion by November 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,328.55 and is scheduled for completion by December 31, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,664.90 to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable pharmaceutical used to treat autoimmune conditions. This firm fixed-price delivery order is not set-aside and represents a competitively awarded contract with a completion date of December 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, valued at $1,591.96, is scheduled for completion by December 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL. This competitive, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 30, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $1,210.98 and is scheduled for completion by November 21, 2025. The contract represents a non-set-aside award, indicating it was competitively awarded to AmerisourceBergen based on its demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $1,591.96, represents a non-competitive set-aside award and is scheduled for completion by December 17, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,872.14 on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating autoimmune conditions. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKGRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $16,861.64, is scheduled for completion by December 31, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was awarded on a competitive basis without any set-aside designation, reflecting the company's ability to meet federal procurement standards through open competition. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a flexible contract vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, and other medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 12/29/25 |